Contralateral Prophylactic Mastectomy Decision-Making: The Partners’ Perspective-Reference-Cited by-同舟云学术

Contralateral Prophylactic Mastectomy Decision-Making: The Partners’ Perspective

Published:2023-08-12 Issue:10 Volume:30 Page:6268-6274
ISSN:1068-9265
Container-title:Annals of Surgical Oncology
language:en
Short-container-title:Ann Surg Oncol

Author:

Nash Amanda L.^ORCID,Bloom Diane L.,Chapman Brittany M.,Wheeler Stephanie B.,McGuire Kandace P.,Lee Clara N.,Weinfurt Kevin,Rosenstein Donald L.,Plichta Jennifer K.,Vann Julie C. Jacobson,Hwang E. Shelley

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Surgery

Link

https://link.springer.com/content/pdf/10.1245/s10434-023-14022-0.pdf

Reference28 articles.

1. (NCCN) NCCN. NCCN clinical practice guidelines in oncology. Breast Cancer Version 4.2022. https://www.nccn.org/professionals/physician_gls/pdf/breast.pdf. Accessed 6 Jan 2023.

2. Sabel MS, Kraft CT, Griffith KA, et al. Differences between breast conservation-eligible patients and unilateral mastectomy patients in choosing contralateral prophylactic mastectomies. Breast J. 2016;22:607–15. https://doi.org/10.1111/tbj.12648.

3. Wong SM, Freedman RA, Sagara Y, Aydogan F, Barry WT, Golshan M. Growing use of contralateral prophylactic mastectomy despite no improvement in long-term survival for invasive breast cancer. Ann Surg. 2017;265:581–9. https://doi.org/10.1097/SLA.0000000000001698.

4. Baskin AS, Wang T, Bredbeck BC, Sinco BR, Berlin NL, Dossett LA. Trends in contralateral prophylactic mastectomy utilization for small unilateral breast cancer. J Surg Res. 2021;262:71–84. https://doi.org/10.1016/j.jss.2020.12.057.

5. Nelson JA, Rubenstein RN, Haglich K, et al. Analysis of a trend reversal in U.S. lumpectomy rates from, through 2017 using 3 nationwide data sets. JAMA Surg. 2005;2022(157):702–11. https://doi.org/10.1001/jamasurg.2022.2065.